[5-(2-Amino-6-oxo-1,6-dihydro-purin-9-yl)-pentyl]-phosphonic acid

ID: ALA267803

Chembl Id: CHEMBL267803

PubChem CID: 135410344

Max Phase: Preclinical

Molecular Formula: C10H16N5O4P

Molecular Weight: 301.24

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Synonyms: 9-(5-Phosphonopentyl)Guanine

Canonical SMILES:  Nc1nc(O)c2ncn(CCCCCP(=O)(O)O)c2n1

Standard InChI:  InChI=1S/C10H16N5O4P/c11-10-13-8-7(9(16)14-10)12-6-15(8)4-2-1-3-5-20(17,18)19/h6H,1-5H2,(H2,17,18,19)(H3,11,13,14,16)

Standard InChI Key:  ZQMIYPAADORARG-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA267803

    ---

Associated Targets(Human)

PNP Tclin Purine nucleoside phosphorylase (774 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HPRT1 Tchem Hypoxanthine-guanine phosphoribosyltransferase (369 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Pnp Purine-nucleoside phosphorylase (70 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 301.24Molecular Weight (Monoisotopic): 301.0940AlogP: 0.46#Rotatable Bonds: 6
Polar Surface Area: 147.38Molecular Species: ACIDHBA: 7HBD: 4
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 5#RO5 Violations (Lipinski):
CX Acidic pKa: 1.87CX Basic pKa: 0.89CX LogP: -0.62CX LogD: -2.67
Aromatic Rings: 2Heavy Atoms: 20QED Weighted: 0.44Np Likeness Score: -0.63

References

1. Chern JW, Lee HY, Chen CS, Shewach DS, Daddona PE, Townsend LB..  (1993)  Nucleosides. 5. Synthesis of guanine and formycin B derivatives as potential inhibitors of purine nucleoside phosphorylase.,  36  (8): [PMID:8478902] [10.1021/jm00060a010]
2. Guida WC, Elliott RD, Thomas HJ, Secrist JA, Babu YS, Bugg CE, Erion MD, Ealick SE, Montgomery JA..  (1994)  Structure-based design of inhibitors of purine nucleoside phosphorylase. 4. A study of phosphate mimics.,  37  (8): [PMID:8164252] [10.1021/jm00034a008]
3. Niwas S, Chand P, Pathak VP, Montgomery JA..  (1994)  Structure-based design of inhibitors of purine nucleoside phosphorylase. 5. 9-Deazahypoxanthines.,  37  (15): [PMID:8057293] [10.1021/jm00041a027]
4. Česnek M, Hocková D, Holý A, Dračínský M, Baszczyňski O, Jersey Jd, Keough DT, Guddat LW..  (2012)  Synthesis of 9-phosphonoalkyl and 9-phosphonoalkoxyalkyl purines: evaluation of their ability to act as inhibitors of Plasmodium falciparum, Plasmodium vivax and human hypoxanthine-guanine-(xanthine) phosphoribosyltransferases.,  20  (2): [PMID:22178188] [10.1016/j.bmc.2011.11.034]

Source